Sponsor

Instytut Pomnik Centrum Zdrowia Dziecka

Poland Aleja Dzieci Polskich 20, 04-730 Warsaw, Poland

About the sponsor

Clinical research includes glycogen storage disease type Ib, with attention to neutropenia and treatment options aimed at improving hematologic and metabolic complications in children.

Glycogen storage disease type Ib
Neutropenia
Pediatric metabolic disorders

The sponsor’s work in this area reflects interest in rare inherited conditions requiring targeted supportive and disease-specific care.

About Specializations

Instytut Pomnik Centrum Zdrowia Dziecka runs clinical trials in conditions such as Epilepsy, Tuberous sclerosis complex, Brain stem glioma, Colitis ulcerative, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

8 clinical trials

Tuberous sclerosis complex+1

Recruiting

Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

Registered drug

Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

Registered drug

Poland

Participants:0–17 years
Substances:Sirolimus
Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Contact Research Centre

Tuberous sclerosis complex+1

Recruiting

Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

Registered drug

Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

Registered drug

Poland

Participants:0–17 years · 18–64 years
Substances:Sirolimus
Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Contact Research Centre

Brain stem glioma

Recruiting

Study on the Effectiveness of Sirolimus and Trametinib for Treating Diffuse Intrinsic Pontine Glioma in Children Aged 3-18 Years

Registered drugNo placebo

Study on the Effectiveness of Sirolimus and Trametinib for Treating Diffuse Intrinsic Pontine Glioma in Children Aged 3-18 Years

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Sirolimus
Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Contact Research Centre

Colitis ulcerative

Recruiting

Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

Registered drugNo placebo

Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Infliximab
Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Contact Research Centre

Medulloblastoma recurrent

Not yet recruiting

A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

Registered drugNo placebo

A study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Everolimus
Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Contact Research Centre

Cortical dysplasia+1

Not recruiting

Study on the Safety and Effectiveness of Sirolimus for Treating Drug-Resistant Epilepsy in Children with Rare Brain Disorders Linked to mTOR Pathway Activation

Registered drugNo placebo